JUNE 19-21, 2023


Tissue Engineering and Disease Modeling

Symposium Chair

Thomas J. Webster4D printed nano biomaterials: Applications for on-demand drug delivery, improved tissue growth, stem cell delivery, and so much more
Thomas J. Webster
Chief Scientific Advisor, Interstellar Therapeutics


Key Speakers

Yu Shrike Zhang3D Bioprinting for High-Content Tissue Engineering
Yu Shrike Zhang
Professor, Harvard Medical School

Houssam BouloussaA Novel, Scalable, and Versatile Biocidal Surface Modification Technology to Prevent and Mitigate Biofilm Formation: An In-Vivo Safety and Efficacy Study
Houssam Bouloussa
Co-founder, DeBogy Molecular, Inc

David Medina CruzBacterial and human cell-synthesized metal nanomaterials: turning bacterial pathogens and human cells into clinical assets
David Medina Cruz
Co-founder, SynCell Biotechnology

Hongjun WangBiomimetic Nanofiber-Enabled Rapid Creation of Skin Grafts
Hongjun Wang
Professor, Stevens Institute of Technology

Tissue engineering encompasses aspects of cells, materials, and biochemical, and physiochemical cues to restore, maintain, or replace tissue function. Disease modeling, whether it be in vitro or in vivo, aims to establish systems that resemble human diseases to improve our understanding of the mechanism of diseases or develop new therapies and diagnostic tools. Though these two areas are distinctly different in their end goals, there is significant conceptual and design overlap. Presentations in this session focus all aspects of tissue engineering or disease modeling including biomaterials, cells, growth factors, mechanical stimuli, and in vivo models and testing.

Back to Top ↑

2023 Symposium Sessions

9:00Tissue Engineering
4:00Tissue Engineering - Posters

2023 Symposium Program

Monday June 19

9:00Tissue EngineeringChesapeake 12
Session chair: Thomas Webster, Interstellar Therapeutics, US
9:00A Novel, Biocidal and Permanent Surface Modification Technology to Protect Medical and Non-Medical Surfaces
H. Bouloussa, DeBogy Molecular, Inc., US
9:25Bacterial and human cell-synthesized metal nanomaterials: turning bacterial pathogens and human cells into clinical assets
D. Medina Cruz, SynCell Biotechnology, US
9:50Design of Biomimetic ECM-like Matrices for Guided Tissue Formation
H. Wang, Stevens Institute of Technology, US
10:25Converged Biofabrication Technologies for High-Content Tissue Model Engineering
Y. Shrike Zhang, Harvard Medical School, US
10:50Human Clinical Tissue Engineering Trials
T.J. Webster, Interstellar Therapeutics, US
11:10Gelatin Methacryloyl Granular Hydrogels: High-throughput Microgel Fabrication, Lyophilization, Chemical Assembly, and 3D Bioprinting
A. Sheikhi, The Pennsylvania State University, US
11:30Absolute Quantification of Genomic Targets for Cell Counting
M. Cauble, H-J He, J. Almeida, S. Sarkar, National Institute of Standards and Technology, US
11:50Light Transmission Aggregometry Method to Measure Tumor Cell Cluster Dissociation
B. Schnoor, R.K. Kottana, A.L. Papa, George Washington University, US
4:00Tissue Engineering - PostersExpo Hall AB
Developing Customizable Scaffolds with Antimicrobial Properties for Vascular Tissue Regeneration using Low Temperature Plasma (LTP)
K. Vig, Alabama State University, US
Topics & Application Areas
  • Cell sourcing
  • Genetic and metabolic engineering
  • Growth factor and cytokines
  • Tissue stimulation devices
  • Biomaterials for tissue engineering or disease modeling
  • Three-dimensional cell culture models
  • Organ-on-a-chip
  • Microphysiological systems
  • Drug screening platforms
  • Engineered models of diseases
  • Animal models
  • Models to study host-microorganism interactions and infections
  • Other

Sponsor & Exhibitor Opportunities

To receive announcements and news, please join our mailing list.

Click here to add this event to your calendar.
Sponsors & Partners
SBIR/STTR Agency Partners